Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion type Assertion NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_head.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion description "[Four groups were studied: group 1 (aged 4-64 yr) islet cell antibody-positive (ICA+) prediabetic subjects, 10 of 19 (53%) were CF-SG+; group 2 (aged 6-14 yr) ICA- prediabetic subjects (first-degree relatives of IDDM subjects with either transient hyperglycemia, impaired oral glucose tolerance, and/or first-phase insulin release after intravenous glucose tolerance testing), 4 of 9 (44%) were CF-SG+ (2 of the 4 ICA- CF-SG+ subjects have progressed to IDDM); group 3 (aged 1.5-43 yr) ICA+ IDDM subjects (less than or equal to 1 yr duration) 6 of 10 (60%) were CF-SG+; and group 4 (aged 8-59 yr) ICA- IDDM subjects (less than or equal to 1 yr duration), 2 of 11 (18%) were CF-SG+.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_provenance.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion evidence source_evidence_literature NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_provenance.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion SIO_000772 2653745 NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_provenance.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion wasDerivedFrom befree-2016 NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_provenance.
- NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_assertion wasGeneratedBy ECO_0000203 NP1295433.RAR9mtxcY4UsOLDXSMWz_WMU0xhO7xhenit8eMzFhij1M130_provenance.